Your browser doesn't support javascript.
loading
ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection.
Mielke, Dieter; Bandawe, Gama; Zheng, Jie; Jones, Jennifer; Abrahams, Melissa-Rose; Bekker, Valerie; Ochsenbauer, Christina; Garrett, Nigel; Abdool Karim, Salim; Moore, Penny L; Morris, Lynn; Montefiori, David; Anthony, Colin; Ferrari, Guido; Williamson, Carolyn.
Afiliación
  • Mielke D; Department of Surgery, Duke University, Durham, North Carolina, United States of America.
  • Bandawe G; Institute of Infectious Diseases and Molecular Medicine and Division of Medical Virology, University of Cape Town, Cape Town, South Africa.
  • Zheng J; Institute of Infectious Diseases and Molecular Medicine and Division of Medical Virology, University of Cape Town, Cape Town, South Africa.
  • Jones J; Malawi University of Science and Technology, Thyolo, Malawi.
  • Abrahams MR; University of Alabama at Birmingham, Department of Medicine, Birmingham, Alabama, United States of America.
  • Bekker V; University of Alabama at Birmingham, Department of Medicine, Birmingham, Alabama, United States of America.
  • Ochsenbauer C; Institute of Infectious Diseases and Molecular Medicine and Division of Medical Virology, University of Cape Town, Cape Town, South Africa.
  • Garrett N; National Institute for Communicable Diseases, Johannesburg, South Africa.
  • Abdool Karim S; University of Alabama at Birmingham, Department of Medicine, Birmingham, Alabama, United States of America.
  • Moore PL; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa.
  • Morris L; Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu Natal, Durban, South Africa.
  • Montefiori D; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa.
  • Anthony C; Department of Epidemiology, Columbia University, New York, New York, United States of America.
  • Ferrari G; National Institute for Communicable Diseases, Johannesburg, South Africa.
  • Williamson C; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa.
PLoS Pathog ; 17(11): e1010046, 2021 11.
Article en En | MEDLINE | ID: mdl-34788337
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anticuerpos Anti-VIH / Linfocitos T CD4-Positivos / Infecciones por VIH / VIH-1 / Anticuerpos Neutralizantes / Evasión Inmune / Citotoxicidad Celular Dependiente de Anticuerpos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: PLoS Pathog Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anticuerpos Anti-VIH / Linfocitos T CD4-Positivos / Infecciones por VIH / VIH-1 / Anticuerpos Neutralizantes / Evasión Inmune / Citotoxicidad Celular Dependiente de Anticuerpos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: PLoS Pathog Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos